WANG Xiaoli,RONG Hua,PAN Siwen,et al.Neuroprotective effect and mechanism of eleutheroside B on Parkinson’s disease model mice by regulating the IKKβ/NF-κB signaling pathway[J].ZHONGGUO YAOFANG,2026,37(08):998-1002.
WANG Xiaoli,RONG Hua,PAN Siwen,et al.Neuroprotective effect and mechanism of eleutheroside B on Parkinson’s disease model mice by regulating the IKKβ/NF-κB signaling pathway[J].ZHONGGUO YAOFANG,2026,37(08):998-1002. DOI: 10.6039/j.issn.1001-0408.2026.08.05.
Neuroprotective effect and mechanism of eleutheroside B on Parkinson’s disease model mice by regulating the IKKβ/NF-κB signaling pathway
To investigate the neuroprotective effect and mechanism of eleutheroside B (ELB) on Parkinson’s disease (PD) model mice by regulating the IκB kinase β (IKKβ)/nuclear factor-κB (NF-κB) signaling pathway.
METHODS
2
Fifty mice were randomly divided into normal control group, model group, positive control group (selegiline hydrochloride, 10 mg/kg), and ELB low-dose and high-dose groups (80, 160 mg/kg), with 10 mice in each group. Each group was given relevant medicine or normal saline intragastrically for 14 consecutive days. Starting from the 10th day of administration, the model group and all administration groups were intraperitoneally injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 30 mg/kg, for five consecutive days to establish the chronic PD model.
After the last administration for 24 h, six mice were randomly selected from each group to test their behavioral abilities; detect the levels of interleukin-1β (IL-1β), IL-10, tumor necrosis factor-α (TNF-α) in brain tissue and their mRNA expressions were measured, and positive expression of tyrosine hydroxylase (TH), protein expressions of TH,
α
-synuclein (
α
-syn), ionized calcium-binding adaptor molecule 1 (Iba-1), as well as phosphorylation levels of IKKβ and NF-κB p65 proteins in the brain tissue were detected. The ultrastructure of neurons in substantia nigra was observed.
RESULTS
2
Compared with the model group, rotarod endurance time and climbing score of each administration group (except for the ELB low-dose group) were increased significantly (
P
<0.05), while the levels and mRNA expressions of IL-1β, TNF-α,
α
-syn, and Iba-1, as well as phosphorylation levels of IKKβ and NF-κB p65 proteins in brain tissue were decreased significantly (except for TNF-α in the ELB low-dose group). Conversely, the level and mRNA expression of IL-10 (except for the ELB low-dose group), TH positive expression and protein expressions were significantly increased (
P
<0.05). Typical neurodegenerative pathological changes, such as neuronal karyopyknosis, mitochondrial swelling and vacuolization, and endoplasmic reticulum dilation, all showed varying degrees of improvement.
CONCLUSIONS
2
ELB may exert neuroprotective effects by inhibiting the activation of the IKKβ/NF-κB signaling pathway, alleviating inflammatory responses, reducing abnormal
α
-syn aggregation and neuronal loss, and further improving motor dysfunction in PD mice.
关键词
Keywords
references
BEN-SHLOMO Y , DARWEESH S , LLIBRE-GUERRA J , et al . The epidemiology of Parkinson’s disease [J ] . Lancet , 2024 , 403 ( 10423 ): 283 - 292 .
MORRIS H R , SPILLANTINI M G , SUE C M , et al . The pathogenesis of Parkinson’s disease [J ] . Lancet , 2024 , 403 ( 10423 ): 293 - 304 .
ZHANG J , ZHANG R , LI W , et al . IκB kinase β (IKKβ):structure,transduction mechanism,biological function,and discovery of its inhibitors [J ] . Int J Biol Sci , 2023 , 19 ( 13 ): 4181 - 4203 .
ZHANG Z C , WU Y H , SHI D , et al . Acanthopanax senticosus improves cognitive impairment in Alzheimer’s disease by promoting the phosphorylation of the MAPK signaling pathway [J ] . Front Immunol , 2024 , 15 : 1383464 .
HE Y C , ZHANG H Y , ZHANG X , et al . Eleutheroside B alleviates oxidative stress and neuroinflammation by inhibiting the JAK2/STAT3 signaling pathway in a rat high altitude cerebral edema model [J ] . Front Pharmacol , 2024 , 15 : 1506483 .
RONG H , LI X M , YU C L , et al . Targeting the Nrf2-dependent mechanism of b-ecdysterone in attenuating the motor dysfunction in the MPTP/pro-induced Parkinson’s disease mice model [J ] . Folia Neuropathol , 2024 , 62 ( 1 ): 83 - 95 .
DELIZ J R , TANNER C M , GONZALEZ-LATAPI P . Epidemiology of Parkinson’s disease:an update [J ] . Curr Neurol Neurosci Rep , 2024 , 24 ( 6 ): 163 - 179 .
CHU Y P , HIRST W D , FEDEROFF H J , et al . Nigrostriatal tau pathology in Parkinsonism and Parkinson’s disease [J ] . Brain , 2024 , 147 ( 2 ): 444 - 457 .
LIM S Y , KLEIN C . Parkinson’s disease is predominantly a genetic disease [J ] . J Parkinsons Dis , 2024 , 14 ( 3 ): 467 - 482 .
WANG L J , YI H Y , LIANG X J , et al . Plasma TNF-α and phosphorylated α-syn are associated with fatigue in patients with Parkinson’s disease [J ] . J Neuroimmunol , 2023 , 385 : 578222 .
GUO Q , JIN Y Z , CHEN X Y , et al . NF-κB in biology and targeted therapy:new insights and translational implications [J ] . Signal Transduct Target Ther , 2024 , 9 : 53 .